CD40 ligand triggers interleukin-6 mediated B cell differentiation

被引:51
作者
Urashima, M
Chauhan, D
Hatziyanni, M
Ogata, A
Hollenbaugh, D
Aruffo, A
Anderson, KC
机构
[1] DANA FARBER CANC INST,DIV HEMATOL MALIGNANCIES,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[3] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
关键词
B cell; CD40; ligand; interleukin-6 (IL-6); IL-10; IL-4;
D O I
10.1016/0145-2126(95)00098-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interleukin-6 (IL-6) is the major cytokine to date mediating antigen (Ag)- or mitogen-driven B cell differentiation. Recently, CD40 ligand (CD40L), with the co-stimulatory cytokines IL-4 and IL-10, has been shown to trigger immunoglobulin (Ig) secretion and class switching. In the present report, we have examined the role of IL-6 in mediating B cell differentiation and Ig secretion triggered with CD40L and/or these cytokines. Culture of splenic B cells with CD40L triggered (1) significant (5.4-fold) increases in IL-6 secretion; (2) differentiation, evidenced by sequential loss of B cell (CD20, CD21) and acquisition of plasma cell (CD38, PCA-1) surface antigens (Ags); and (3) Ig secretion. Interleukin-4 increased both IL-6 and IgG secretion stimulated by CD40L. Interleukin-10+ CD40L triggered 100-fold increments in IgG, IgA and IgM secretion, but IL-10 suppressed IL-6 secretion triggered with CD40L+/-IL-4. Exogenous IL-6 can further increase IgG secretion induced by CD40L + IL-10; moreover, the anti-IL-6 monoclonal antibody partially blocked IgG secretion triggered by CD40L+/-IL-4 or IL-10. Finally, IL-10 suppressed differentiation of B cells induced by CD40L. These studies suggest that CD40L augments Ig secretion in at least two mechanisms: by triggering IL-6 secretion and related differentiation, and by priming B cells for responsiveness to IL-10. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:507 / 515
页数:9
相关论文
共 56 条
  • [1] ANDERSON KC, 1985, J IMMUNOL, V134, P820
  • [2] EXPRESSION OF HUMAN B CELL-ASSOCIATED ANTIGENS ON LEUKEMIAS AND LYMPHOMAS - A MODEL OF HUMAN B-CELL DIFFERENTIATION
    ANDERSON, KC
    BATES, MP
    SLAUGHENHOUPT, BL
    PINKUS, GS
    SCHLOSSMAN, SF
    NADLER, LM
    [J]. BLOOD, 1984, 63 (06) : 1424 - 1433
  • [3] ANDERSON KC, 1992, BLOOD, V80, P2797
  • [4] ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671
  • [5] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40
    ARMITAGE, RJ
    FANSLOW, WC
    STROCKBINE, L
    SATO, TA
    CLIFFORD, KN
    MACDUFF, BM
    ANDERSON, DM
    GIMPEL, SD
    DAVISSMITH, T
    MALISZEWSKI, CR
    CLARK, EA
    SMITH, CA
    GRABSTEIN, KH
    COSMAN, D
    SPRIGGS, MK
    [J]. NATURE, 1992, 357 (6373) : 80 - 82
  • [6] CD40 LIGAND IS A T-CELL GROWTH-FACTOR
    ARMITAGE, RJ
    TOUGH, TW
    MACDUFF, BM
    FANSLOW, WC
    SPRIGGS, MK
    RAMSDELL, F
    ALDERSON, MR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) : 2326 - 2331
  • [7] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    ARUFFO, A
    FARRINGTON, M
    HOLLENBAUGH, D
    LI, X
    MILATOVICH, A
    NONOYAMA, S
    BAJORATH, J
    GROSMAIRE, LS
    STENKAMP, R
    NEUBAUER, M
    ROBERTS, RL
    NOELLE, RJ
    LEDBETTER, JA
    FRANCKE, U
    OCHS, HD
    [J]. CELL, 1993, 72 (02) : 291 - 300
  • [8] BAHCHEREAU J, 1991, NATURE, V359, P678
  • [9] BANCHEREAU J, 1900, SCIENCE, V250, P70
  • [10] ROLE OF INTERLEUKIN-6 IN THE GROWTH OF MYELOMA-DERIVED CELL-LINES
    BARUT, BA
    ZON, LI
    COCHRAN, MK
    PAUL, SR
    CHAUHAN, D
    MOHRBACHER, A
    FINGEROTH, J
    ANDERSON, KC
    [J]. LEUKEMIA RESEARCH, 1992, 16 (10) : 951 - 959